Beware: Adverse Skin Reactions to Alcoholism Treatment Drug

Link:

The U.S. Food and Drug Administration (FDA) has issued an alert for healthcare professionals to be aware of the risk for adverse injection site reactions in their patients who receive naltrexone (Vivitrol). Vivitrol is an extended-release version of the generic drug naltrexone marketed by Cephalon Inc. and is manufactured by Cambridge-based Alkermes, Inc. It was approved in 2006 to treat alcohol dependence in patients who show they can abstain from drinking prior to receiving the drug therapy.

Translate into: cs pl ru de ja nl es ar pt fr el it ko tr no fi hu sv ro hi bg et lt lt sk tl iw hr id ca lv sl sr uk vi
Link: http://www.healthnews.com/medical-updates/beware-adverse-skin-reactions-alcoholism-treatment-drug-1576.html
Complete RSS
<<< Back

Beware: Adverse Skin Reactions to Alcoholism Treatment Drug - témata

Adverse, Skin, Reactions, Alcoholism, Treatment, Drug, Beware: Adverse Skin Reactions, Alcoholism Treatment Drug , Food, Administration, (FDA), (Vivitrol), Vivitrol, Cephalon, Inc, Cambridge-based, Alkermes, 2006, The U.S. Food, Drug Administration (FDA), (Vivitrol). Vivitrol, Cephalon Inc., Cambridge-based Alkermes, Inc., Beware: Adverse Skin Reactions to Alcoholism Treatment Drug,

Beware: Adverse Skin Reactions to Alcoholism Treatment Drug

Beware: Adverse Skin Reactions to Alcoholism Treatment Drug - témata

Podobné zprávy

RSS sources

Your own sources

Public sources